Presentation is loading. Please wait.

Presentation is loading. Please wait.

CHAPTER 12 DISORDERS OF HEMOSTASIS Essentials of Pathophysiology.

Similar presentations


Presentation on theme: "CHAPTER 12 DISORDERS OF HEMOSTASIS Essentials of Pathophysiology."— Presentation transcript:

1 CHAPTER 12 DISORDERS OF HEMOSTASIS Essentials of Pathophysiology

2 PRE LECTURE QUIZ (TRUE/FALSE)  Platelets are also known as leukocytes.  Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder that affects the normal function and formation of platelets.  Disseminated intravascular coagulation is a condition that results in massive systemic bleeding, but coagulation function remains normal.  The use of aspirin and other nonsteroidal anti- inflammatory drugs (NSAIDs) has been identified as a cause of impaired platelet function.  Bleeding can occur as a result of a decrease in the number of circulating platelets or because of impaired platelet function. F T T T T

3 PRE LECTURE QUIZ  _________________ is the orderly, stepwise process for stopping bleeding that involves vasospasm, formation of a platelet plug, and development of a fibrin clot.  A decrease in the number of circulating platelets is known as _________________________.  Hemophilia A is an X-linked recessive disorder that involves a deficiency of factor _________________.  ________________ disorders are caused by defects associated with platelets, coagulation factors, and vessel integrity.  Vitamin _______________, a fat-soluble vitamin that is continuously being synthesized by intestinal bacteria, is necessary for normal activity of factors VII, IX, and X and prothrombin. Bleeding K Hemostasis thrombocytopenia VIII

4 HEMOSTASIS  Stopping blood flow  Normal:  Blood usually fluid  Seals broken blood vessels  Abnormal:  Inappropriate clotting  Insufficient clotting

5 PLATELETS (THROMBOCYTES)  Thrombopoietin  Made in liver, kidney, smooth muscle, bone marrow  Megakaryocytes formed in bone marrow  Break apart to form many platelets  Platelets live 8–9 days in circulation  Many are stored in spleen  Released when needed

6 PLATELET STRUCTURE

7 QUESTION All but which of the following are true about platelets? a. An enzyme called erythropoietin stimulates their production. b. They are made from megakaryocytes. c. They originate from the bone marrow. d. They are stored in the spleen.

8 ANSWER a. An enzyme called erythropoietin stimulates their production. Rationale: Erythropoietin stimulates the production of RBCs (erythrocytes). The word literally means erythrocyte production. Platelet formation is stimulated by thrombopoietin (thrombus/clot production).

9 CLOTTING CASCADE

10 MEDIATORS OF HEMOSTASIS  Chemicals produced by platelets  Released at an injury to:  Start clotting by reacting with blood proteins  Help platelets stick together  Stimulate wound healing  Help platelets stick to vessel wall  Constrict blood vessels

11 COAGULATION FACTORS  Plasma proteins  Most are synthesized by liver  von Willebrand factor made by endothelium  Circulate as inactive procoagulation factors  Calcium

12 QUESTION What is the effect of von Willebrand disease on the platelets? a. Increased platelet aggregation b. Decreased platelet aggregation c. Increased platelet formation d. Decreased platelet formation

13 ANSWER b. Decreased platelet aggregation Rationale: Von Willebrand disease is the most common hereditary bleeding disorder. It is caused by a deficiency or defect in vWF (which carries a clotting factor). The result of less clotting factor is an inability to clot.

14 VESSEL SPASM

15 CYCLOOXYGENASE ENZYMES (COX) PRODUCE MEDIATORS OF HEMOSTASIS  Celebrex is a drug that blocks COX-2  Given to block inflamation  People taking Celebrex develop increased TXA 2 levels  What problems might they have? COX-1 COX-2 arachidonic acid thromboxane A 2 Prostacyclin Macrophage Activation & Inflamation mediation NSAIDs inhibit both COX 1 &2 COX 1 is needed for intestinal mucosa Problems here?

16 INTRINSIC AND EXTRINSIC PATHWAYS Common Pathway

17 PLATELETS Platelet aggregate with fibrin threads Activated platelets Non activated platelet

18 FIBRINOGEN  FIBRIN

19 SCENARIO A man had a stroke and the doctor gave him tissue plasminogen activator (TPA).  Why? What is the doctor trying to accomplish?  One of the man’s relatives wondered why they did not give him heparin or warfarin instead  What is the difference? Why might TPA be more appropriate?

20 HYPERCOAGULABILITY  Increased platelet number  Platelet aggregation  Endothelial damage  Increased procoagulation factors  Decreased anticoagulation factors

21 QUESTION True or False. Hypercoagulability states increase the risk of thrombus formation.

22 ANSWER True Rationale: Hyper- as a prefix means “over” or “too much.” Coagulation/coagulability means “clotting/the ability to clot.” Hypercoagulability means “increased ability to clot or form thrombi.”

23 SCENARIO: A woman with lupus develops breast cancer.  She is given radiation therapy  She begins to develop nosebleeds and bruising  Her menstrual period is abnormally heavy Question: Why did this happen?

24 PLATELET DISORDERS  Decreased platelet levels (thrombocytopenia)  Decreased production  Increased destruction  Platelets used up in forming clots  Impaired platelet function

25 DIC

26 QUESTION True or False. Platelet disorders are bleeding disorders.

27 ANSWER True Rationale: Because the platelet’s job is to clot, platelet disorders mean that the platelets cannot do that job. An inability to clot results in bleeding/bleeding disorders.


Download ppt "CHAPTER 12 DISORDERS OF HEMOSTASIS Essentials of Pathophysiology."

Similar presentations


Ads by Google